Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12051
CALL
OFS Capital
OFS
$48.1M
| $64.6K | ﹤0.01% |
8,000
-6,500
| -45% | -$53.3K |
|
12052
CALL
VanEck Agribusiness ETF
MOO
$976M
| $64.5K | ﹤0.01% |
1,000
-700
| -41% | -$49.7K |
|
|
HUYA
12053
CALL
Huya Inc
HUYA
$529M
| $64.5K | ﹤0.01% |
21,000
-12,600
| -38% | -$44.7K |
|
|
KLRS
12054
Kalaris Therapeutics
KLRS
$97.1M
| $64.5K | ﹤0.01% |
6,674
+3,013
| +82% | +$45.6K |
|
12055
PUT
Bally's
BALY
$685M
| $64.4K | ﹤0.01% |
3,600
-14,000
| -80% | -$247K |
|
|
JBIO
12056
PUT
Jade Biosciences
JBIO
$1.57B
| $64.4K | ﹤0.01% |
694
+668
| +2,569% | +$57.6K |
|
12057
PUT
Amplitude
AMPL
$1.63B
| $64.4K | ﹤0.01% |
6,100
-2,600
| -30% | -$26K |
|
12058
CALL
German American Bancorp
GABC
$1.93B
| $64.4K | ﹤0.01% |
1,600
+900
| +129% | +$38.1K |
|
12059
PUT
Goosehead Insurance
GSHD
$2.35B
| $64.3K | ﹤0.01% |
600
-6,800
| -92% | -$742K |
|
|
GATO
12060
CALL
DELISTED
Gatos Silver, Inc.
GATO
| $64.3K | ﹤0.01% |
4,600
-15,500
| -77% | -$252K |
|
12061
PUT
Relay Therapeutics
RLAY
$4.35B
| $64.3K | ﹤0.01% |
15,600
-2,000
| -11% | -$10.9K |
|
12062
SOPHiA GENETICS
SOPH
$638M
| $64.2K | ﹤0.01% |
20,586
+5,094
| +33% | +$17.3K |
|
12063
PUT
Perma-Fix Environmental Services
PESI
$369M
| $64.2K | ﹤0.01% |
5,800
-1,200
| -17% | -$15.8K |
|
12064
CALL
Timberland Bancorp
TSBK
$358M
| $64.1K | ﹤0.01% |
+2,100
| New | +$65.7K |
|
12065
Fusion Fuel Green
HTOO
$16.8M
| $64K | ﹤0.01% |
+3,251
| New | +$58.9K |
|
|
ELVA
12066
Electrovaya
ELVA
$394M
| $64K | ﹤0.01% |
+25,821
| New | +$60.4K |
|
12067
PUT
Valens Semiconductor
VLN
$210M
| $64K | ﹤0.01% |
+24,600
| New | +$49.3K |
|
12068
Aura Biosciences
AURA
$797M
| $63.9K | ﹤0.01% |
7,778
+6,767
| +669% | +$63.7K |
|
|
AUTL
12069
PUT
Autolus Therapeutics
AUTL
$572M
| $63.9K | ﹤0.01% |
27,200
+26,400
| +3,300% | +$89.2K |
|
12070
PUT
SkinHealth Systems
SKIN
$86.8M
| $63.9K | ﹤0.01% |
40,200
-194,000
| -83% | -$305K |
|
|
WCLD
12071
CALL
WisdomTree Cloud Computing Fund
WCLD
$311M
| $63.8K | ﹤0.01% |
1,700
+200
| +13% | +$7.27K |
|
12072
PUT
WSFS Financial
WSFS
$4.17B
| $63.8K | ﹤0.01% |
1,200
-3,300
| -73% | -$180K |
|
12073
CALL
MarineMax
HZO
$1.15B
| $63.7K | ﹤0.01% |
2,200
-10,200
| -82% | -$313K |
|
12074
CALL
HealthStream
HSTM
$846M
| $63.6K | ﹤0.01% |
2,000
| – | – |
|
12075
CALL
Amalgamated Financial
AMAL
$1.53B
| $63.6K | ﹤0.01% |
1,900
+300
| +19% | +$10.3K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.